EUVIMEDEUVIMED entdecken
Open Access

Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery

Habiburrahim Burhanuddin, Cindy Kristina Enggi, Frederika Tangdilintin, Rizki Rachmad Saputra, Purnawan Pontana Putra, Sartini Sartini, Aliyah Aliyah, Rina Agustina, Juan Domínguez-Robles, Muhammad Aswad, Andi Dian Permana

DARU Journal of Pharmaceutical Sciences · 12.12.2024 · 33 (1)

DOI: 10.1007/s40199-024-00546-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 12.12.2024. Verfasst von Habiburrahim Burhanuddin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia. Hauptthemen laut MEDLINE: Amphotericin B, Solubility, Antifungal Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: International Collaboration Research (I-CORE) Program Equity World Class University Indonesia Endowment Fund for Agency (WCU LPDP)-Institute of Research and Co….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Amphotericin B (AMB) is a drug used to treat vulvovaginal candidiasis (VVC), which is a fungal infection affecting the vagina and vulva. Nevertheless, the substance's limited capacity to dissolve in water leads to poor absorption when taken orally, hence diminishing its therapeutic efficacy. In order to address this limitation, β-cyclodextrin (βCD) was used to create AMB in the form of an inclusion complex. OBJECTIVE: This study aims to enhance the solubility and bioavailability of AMB by formulating it into an inclusion complex with βCD. Subsequently, we developed dissolvable microarray patches (DMP) as a novel drug delivery system, optimizing the formulation for improved retention, penetration, and controlled release of AMB. METHODS: The stability of the AMB-βCD inclusion complx (IC) structure has been confirmed by employing molecular docking studies. The formulation of DMP involved the incorporation of IC with polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP). The mechanical strength, ability to be inserted, and propensity to irritate Amphotericin B-Inclusion Complex-Dissolvable Microarray Patches (IC-DMP) were evaluated by laboratory experiments utilizing the porcine vaginal mucosal layer. Further investigations, such as Differential Scanning Calorimetry (DSC), were performed to assess the physicochemical characteristics of the IC. RESULTS: The solubility of the pure medication was greatly enhanced up to fourfold by the inclusion complex. The assessment of IC-DMP exhibited exceptional mechanical robustness and insertion abilities, with no indications of discomfort. Among the formulas tested in ex vivo vaginal kinetic experiments, Formula F3 had the most effective retention in the porcine vaginal mucosal layer. It had an AUC value of 208.02 ± 0.33 h.µg/cm3 and the highest Cmax value of 20.05 ± 0.06 µg/cm3. Therefore, Formula F3 was the most efficient formula in terms of vaginal drug delivery. CONCLUSION: The integration of IC into the DMP system significantly enhances the solubility and bioavailability of AMB, facilitating its absorption in the circulatory system when applied intravaginally for vulvovaginal candidiasis treatment. These promising initial findings support further clinical evaluation of this novel drug delivery system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BSolubilityAntifungal AgentsFemaleAnimalsAdministration, IntravaginalSwinebeta-CyclodextrinsDrug Delivery SystemsVaginaBiological AvailabilityPolyvinyl AlcoholPovidoneCandidiasis, VulvovaginalMolecular Docking Simulation

Stichwörter der Autor:innen

Amphotericin BDissolvable microarray patchesInclusion complexIntravaginal drug deliveryβ-cyclodextrin

Substanzen

Amphotericin BAntifungal Agentsbeta-CyclodextrinsPolyvinyl AlcoholPovidonebetadex

Autor:innen und Institutionen

  • Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia.
  • Department of Chemistry, Faculty of Mathematics and Natural Science, University of Palangka Raya, Central Kalimantan, 73111, Indonesia.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Andalas, Padang, 25163, Indonesia.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, 41012, Seville, Spain.
  • Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia. andi.dian.permana@farmasi.unhas.ac.id.

Förderung

  • International Collaboration Research (I-CORE) Program Equity World Class University Indonesia Endowment Fund for Agency (WCU LPDP)-Institute of Research and Co…

Zitieren

APA

Burhanuddin, H., Enggi, C. K., Tangdilintin, F., Saputra, R. R., Putra, P. P., Sartini, S., Aliyah, A., Agustina, R., Domínguez-Robles, J., Aswad, M., & Permana, A. D. (2024). Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery. DARU Journal of Pharmaceutical Sciences, 33(1). https://doi.org/10.1007/s40199-024-00546-7

Vancouver

Burhanuddin H, Enggi CK, Tangdilintin F, Saputra RR, Putra PP, Sartini S, et al. Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery. DARU Journal of Pharmaceutical Sciences. 2024;33(1). doi:10.1007/s40199-024-00546-7

BibTeX
@article{Burhanuddin2024,
  author = {Burhanuddin, Habiburrahim and Enggi, Cindy Kristina and Tangdilintin, Frederika and Saputra, Rizki Rachmad and Putra, Purnawan Pontana and Sartini, Sartini and Aliyah, Aliyah and Agustina, Rina and Domínguez-Robles, Juan and Aswad, Muhammad and Permana, Andi Dian},
  title = {Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2024},
  volume = {33},
  number = {1},
  doi = {10.1007/s40199-024-00546-7}
}
Kostenlos starten →